ResultsIQ

ResultsIQ › Latest results › Oriental Aromatics Limited

Oriental Aromatics Limited Q4 FY25 earnings call summary

NSE: OAL · BSE: 500078

Earnings call of 29 May 2025, summarised by AI from the filing.

Oriental Aromatics FY25 revenue ₹928 cr, EBITDA ₹93.4 cr nearly doubled; EBITDA margin guidance maintained at 10-12%.

Key takeaways

  1. Change Legacy camphor brands Saraswati and 3 Pine fully internalized, with 60% of powder camphor used internally.
  2. Driver Fragrance division grew with new customer wins and deeper engagement with existing clients.
  3. Risk Camphor and terpene chemicals face pricing pressure and oversupply, compressing margins.

Original filing on BSE

Oriental Aromatics Limited Q1 FY27 results

As filed: Revenue ₹260 cr (+15% year on year), EBITDA ₹19.8 cr (+4% year on year), PAT ₹2.5 cr (+151% year on year), EBITDA margin 7.6% (−79 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹282 cr (+12% year on year), EBITDA ₹19.5 cr (−3% year on year), PAT ₹4.0 cr (+299% year on year), EBITDA margin 6.9% (−101 bps). Score 41 of 100, In line with trend. Revenue growth was in line with the company's own trend; EBITDA growth was below it; profit growth was well above it. EBITDA margin fell 101 bps year on year. Other income 58% of PBT. Tax rate 46%. Share price after the results: +11.6% in 30 days (Nifty 500: +2.5%).
  • Q3 FY26: Revenue ₹252 cr (+13% year on year), EBITDA ₹13.2 cr (−40% year on year), PAT −₹1.9 cr (−127% year on year), EBITDA margin 5.3% (−461 bps). Score 20 of 100, Below trend. Revenue growth was above the company's own trend; EBITDA growth was below it; profit growth was well below it. EBITDA margin fell 461 bps year on year. Revenue fell 7% from last quarter. Share price after the results: −23.9% in 29 days (Nifty 500: −9.6%).
  • Q2 FY26: Revenue ₹271 cr (+14% year on year), EBITDA ₹18.0 cr (−36% year on year), PAT ₹1.0 cr (−93% year on year), EBITDA margin 6.6% (−517 bps). Score 28 of 100, Below trend. Revenue growth was above the company's own trend; EBITDA growth was well below it; profit growth was below it. EBITDA margin fell 517 bps year on year. Other income 100% of PBT. Tax rate 67%. Share price after the results: −14.8% in 30 days (Nifty 500: −0.8%).
  • Q1 FY26: Revenue ₹226 cr (+5% year on year), EBITDA ₹19.0 cr (−14% year on year), PAT ₹1.0 cr (−91% year on year), EBITDA margin 8.4% (−178 bps). Score 23 of 100, Below trend. Revenue growth was below the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 178 bps year on year. Tax rate 67%. Revenue fell 11% from last quarter. Share price after the results: −3.5% in 28 days (Nifty 500: +1.7%).
  • Q4 FY25: Revenue ₹253 cr (+17% year on year), EBITDA ₹20.0 cr (0% year on year), PAT ₹1.0 cr (−90% year on year), EBITDA margin 7.9% (−135 bps). Score 38 of 100, Below trend. Revenue growth was well above the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 135 bps year on year. Tax rate 50%. Profit fell 86% from last quarter. Share price after the results: −8.9% in 30 days (Nifty 500: +3.1%).
  • Q3 FY25: Revenue ₹223 cr (+13% year on year), EBITDA ₹22.0 cr (+57% year on year), PAT ₹7.0 cr (+133% year on year), EBITDA margin 9.9% (+276 bps). Score 54 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA growth was below it. EBITDA margin rose 276 bps year on year. Revenue fell 6% from last quarter.
  • Q2 FY25: Revenue ₹237 cr (+4% year on year), EBITDA ₹28.0 cr (+180% year on year), PAT ₹15.0 cr (+300% year on year), EBITDA margin 11.8% (+741 bps). Score 78 of 100, Above trend. EBITDA margin rose 741 bps year on year. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

Oriental Aromatics Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.